All Biosimilars Interchangeable? FDA Backs Switching With Spotlight On Science

Latest Review From US Agency Finds ‘Zero Difference’ In Risks When Switching

 
• By Dave Wallace
  
No Difference - dictionary definition
The FDA found biosimilar switching produced “zero difference” in key risks • Source: Shutterstock

More from Biosimilars

More from Products